LSC Recent Webinars on BIO

31. Navigating Primary Packaging Challenges, Solutions For Emerging Innovators 12/5/2024

    If you are in the process of developing a complex or sensitive injectable drug, learn about containment solutions to mitigate your risks and help you get your drug to the patient faster.

32. Charting A Successful CMC Journey For Your ADC Drug Product 12/3/2024

    These real-world case studies highlight best practices and strategies to optimize bioconjugate drug product tech transfers and supplies in the clinical or commercial phase.

33. Early Preclinical Development: A Successful Transition To cGMP Manufacturing 12/2/2024

    Explore the development steps that lead to an mRNA construct optimized for your requirements and that meets future-proof cGMP manufacturing requirements, thereby de-risking the development.

34. How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms 11/25/2024

    Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.

35. Manufacturing Strategies And Facility Design For Patient-Centric Delivery 11/21/2024

    Review how to select the optimal manufacturing strategy and leverage technologies for efficient and scalable production of therapeutic proteins. De-risk the supply chain, accelerate time to market, and reduce costs.

36. Using An Adherent Platform To Scale-Up An Upstream Viral Vector Process 11/20/2024

    Gain insight into a helper-dependent adenovirus (HDAd) process that covers everything from bench-scale and optimization to tech transfer.

37. Vector Technology For Improved Expression Control Of Biotherapeutic Proteins 11/19/2024

    Discover enhanced vector technology developed to enable better control of expression in cells, enhance titers, and improve expression stability for a range of biotherapeutic formats.

38. Contamination Control Strategy With QRM Principles 11/19/2024

    Contamination Control Strategies (CCS) have long been a main concept, but advancing requirements and regulatory expectations create a challenge. Learn how to be effective and compliant with your CCS.

39. Innovative Technologies To Accelerate Identification Of High-Quality Clones 11/18/2024

    Cell line development (CLD) is a process often filled with obstacles that can significantly hinder scientific progress. Watch and learn how to overcome common challenges.

40. Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics 11/6/2024

    Unlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.